On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.
The Castellum programme focused on research into new vaccines for animals to prevent the introduction and spread of zoonoses. The goal of the public-private partnership was to make at least one vaccine available for the market, and this goal was achieved. The project has resulted in a new vaccine against Rift Valley fever virus (RVFV). Wageningen Bioveterinary Research (WBVR) has developed and tested the vaccine for safety and efficacy at its laboratory and animal facilities, where it is possible to work safely with zoonotic infectious diseases.
New innovation program
In 2019, the Netherlands Centre for One Health (NCOH) is launching a new Innovation Programme that is funded by the Top Sector Lifesciences and Health. The new programme is also based on a public-private partnership in the field of One Health. The One Health debate on 28 February 2019 will focus on scientific, organisational and administrative insights that emerged from Castellum programme. Relevant themes for the new Innovation Programme will also be discussed. Learn more about Castellum.